Event Details

Turning Point Therapeutics Third Quarter 2019 Conference Call

Nov 04, 2019 at 4:30 PM EST

ABOUT

Management
Board of Directors
Scientific Advisory Board

PIPELINE

Repotrectinib
TPX-0022
TPX-0046
ALK Inhibitor

OUR SCIENCE

Our Approach
Addressing Resistance
Publications

CLINICAL TRIALS

TRIDENT-1
Compassionate Use

NEWS

Press Releases
Publications

CAREERS

Mission and Values
Our Culture
Opportunities

Terms of Use | Copyright © 2021 Turning Point Therapeutics, Inc. | All Rights Reserved